A novel specific peroxisome proliferator‐activated receptor γ (PPARγ) modulator YR4‐42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet‐induced obese mice

AIMS: To evaluate a novel tetrahydroisoquinoline derivative YR4‐42 as a selective peroxisome proliferator‐activated receptor γ (PPARγ) modulator (SPPARM) and explore its anti‐diabetic effects in vitro and in vivo. MATERIALS AND METHODS: Using two standard full PPARγ agonists rosiglitazone and piogli...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Obes Metab
Päätekijät: Huan, Yi, Pan, Xuan, Peng, Jun, Jia, Chunming, Sun, Sujuan, Bai, Guoliang, Wang, Xing, Zhou, Tian, Li, Rongcui, Liu, Shuainan, Li, Caina, Liu, Quan, Liu, Zhanzhu, Shen, Zhufang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Blackwell Publishing Ltd 2019
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6851555/
https://ncbi.nlm.nih.gov/pubmed/31364797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13843
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia